Participant expertise | Gender | Age range (years) | Country | SSD expertise | SSD intervention experience | |
---|---|---|---|---|---|---|
Group A | Healthcare user: sudden onset loss | Female | 30–39 | Spain | 3 years | CROS aid |
Healthcare user: acoustic neuroma | Male | 70–79 | England | 28 years | CROS aid | |
Audiologist and clinical researcher | Male | 60–69 | Netherlands | 32 years | CROS aids/BAHAs cochlear implants | |
Audiologist and clinical researcher | Female | 40–49 | England | 13 years | CROS aids/BAHAs/middle ear implants | |
Group B | Healthcare user: acoustic neuroma | Male | 70–79 | England | 18 years, 10 months | CROS aid |
Healthcare user: sudden onset loss | Male | 60–69 | England | 3 years, 9 months | CROS aid | |
Audiologist | Male | 50–59 | England | 35 years | CROS aids | |
Clinical researcher and commercial representative | Female | 30–39 | England | 10 years | BAHAs/middle ear implants/cochlear implants | |
Group C | Healthcare user: sudden onset loss | Male | 18–29 | England | 1 year, 1 month | CROS aid/BAHA/cochlear implant |
Healthcare user: childhood loss | Male | 70–79 | England | 73 years | CROS aid | |
Clinical researcher and commercial representative | Male | 50–59 | England | 35 years | Cochlear implants | |
Audiologist | Male | 40–49 | Germany | 25 years | CROS aids/BAHAs/cochlear implants |